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Abstract Purpose: Hyperoxia
may induce pulmonary injury and
may increase oxidative stress. In this
retrospective database study we
aimed to evaluate the response to
hyperoxia by intensivists in a Dutch
academic intensive care unit. Meth-
ods: All arterial blood gas (ABG)
data from mechanically ventilated
patients from 2005 until 2009 were
extracted from an electronic storage
database of a mixed 32-bed intensive
care unit in a university hospital in
Amsterdam. Mechanical ventilation
settings at the time of the ABG tests
were retrieved. Results: The results
of 126,778 ABG tests from 5,498
mechanically ventilated patients were
retrieved including corresponding
ventilator settings. In 28,222 (22%) of
the ABG tests the arterial oxygen
tension (PaO2) was[16 kPa
(120 mmHg). In only 25% of the tests
with PaO2[16 kPa (120 mmHg) was
the fraction of inspired oxygen (FiO2)
decreased. Hyperoxia was accepted
without adjustment in ventilator set-
tings if FiO2 was 0.4 or lower.
Conclusion: Hyperoxia is fre-
quently seen but in most cases does
not lead to adjustment of ventilator
settings if FiO2\0.41. Implementa-
tion of guidelines concerning oxygen
therapy should be improved and fur-
ther research is needed concerning the
effects of frequently encountered
hyperoxia.
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Introduction
Mechanical ventilation (MV) provides essential life sup-
port for patients with respiratory failure. Unfortunately,
this life support may cause or aggravate lung injury in
acute respiratory distress syndrome (ARDS). Ventilator
induced lung injury caused by repeated shear stress and
barotrauma can be reduced using protective lung venti-
lation with lower tidal volumes [1]. The ARDS network
study demonstrated a compelling survival advantage
when using low tidal volumes rather than conventional
MV in patients with acute lung injury (ALI) or ARDS [2].
This led to the reappraisal of the goals of ventilatory
support, allowing some hypercapnia, in order to limit
inspiratory pressures and to lower tidal volumes. Not only
barotrauma due to MV, but also hyperoxia can induce
lung injury. Many experimental studies have demon-
strated increased levels of reactive oxygen-derived free
radicals, with an inﬂux of inﬂammatory cells, increased
pulmonary permeability and endothelial cell injury with
the use of a high fraction of inspired oxygen (FiO2)[ 3].
High inspiratory oxygen concentrations induce tissue
hyperoxia and may mask pulmonary injury. Another
detrimental effect of hyperoxia is the development of
resorption atelectasis with increased shunting [4].
Accordingly, together with permissive hypercapnia, a
certain extent of hypoxaemia is accepted. Generally a
target arterial oxygen tension (PaO2)o f[8 kPa
(60 mmHg) is suggested [5]. A Canadian questionnaire
study, however, found considerable variation in the
Intensive Care Med (2011) 37:46–51
DOI 10.1007/s00134-010-2025-z ORIGINALattitudes, beliefs and practices of intensivists in the
management of oxygen therapy. The responses suggested
that most respondents believed that levels of FiO2 up to
0.4 are not harmful and that this is the ideal range of FiO2
when the PaO2 permits [6]. The actual response of in-
tensivists to hyperoxia has never been studied. In this
retrospective cohort study we aimed to study whether
high PaO2 levels lead to adjustments in ventilator settings




The Academic Medical Center (AMC) in Amsterdam is a
teaching hospital where the ICU is a 32-bed ‘‘closed
format’’ department in which medical and surgical
patients (including cardiothoracic and neurosurgical
patients) are under the direct care of the ICU team.
Patients and data collection
The study included all arterial blood gas (ABG) data from
all mechanically ventilated patients from 2005 until 2009.
Data were extracted automatically from the patient data
management system (PDMS) storage database (Metavi-
sion, iMDsoft, Leiden, The Netherlands). Patients on
noninvasive MV were excluded from the study. All
patients received MV with an Evita4 ventilator (Dra ¨ger-
Medical, Best, The Netherlands) or a Galileo ventilator
(Hamilton Medical, Rha ¨zu ¨ns, Switzerland). MV settings
at the time of the ABG tests were retrieved. The following
MV data were recorded: FiO2, measured positive end-
expiratory pressure (PEEP) level, applied tidal volume
(TV), inspiratory:expiratory (I:E) ratio and MV mode.
Prone positioning, recruitment manoeuvres and other
complementary measures that may improve oxygenation
could not be explored in this database study. Every set of
MV and ABG data was compared with the following set.
The second set was then compared with the third, and so
on. For every patient the last ABG test was excluded
because no comparison was possible with a subsequent
determination.
Demographic data were collected from the Dutch
National Intensive Care Evaluation registry and included
age, height, weight and acute physiological and chronic
health evaluation (APACHE) II score. ABGs were
determined routinely half an hour after every MV
adjustment and also when blood glucose levels were
measured. They were determined more frequently in
patients without a good pulse oximetric saturation signal
or on high pressure MV. All ABG test results were made
available on the PDMS and were communicated to the
clinician.
The predicted body weight (PBW) was calculated from
the following formulas: in men, PBW (kg) = 50 ?
0.91(height in centimetres - 152.4); in women, PBW
(kg) = 45.5 ? 0.91(height in centimetres - 152.4) [2].
In order to monitor the response to a certain extent of
oxygenation we categorized the ABG test results into
ﬁve PaO2 groups: \8 kPa (60 mmHg), 8.01–10 kPa
(60–75 mmHg), 10.01–13 kPa (75–98 mmHg), 13.01–
16 kPa (98–120 mmHg), and[16 kPa (120 mmHg). For
the purpose of this study the last group with a PaO2
[16 kPa (120 mmHg) was regarded as hyperoxic.
MV protocol
In the AMC a written MV protocol is available for all
ICU physicians and nurses. Brieﬂy, this protocol advises
pressure-controlled MV or pressure-support MV. In
addition, adaptive support ventilation is used on the
Hamilton Galileo ventilator in patients with an uncom-
plicated postoperative course in whom extubation is
expected within 24 h. The MV protocol is based on an
open lung concept [7]. MV is typically initiated with a
FiO2 0.4–0.6, PEEP C5 cmH2O and I:E ratio 1:2, with a
target PaO2 higher than 10 kPa (75 mmHg). PEEP and
I:E ratio may be adjusted for lung recruitment if nec-
essary. The FiO2 is targeted below 0.6. During
procedures a higher FiO2 is accepted. Prone positioning
is considered if the PEEP is [10 cmH2O and FiO2 is
[0.6. The protocol suggests lowering FiO2 below 0.4
with a target PaO2 higher than 10 kPa (75 mmHg). In
the weaning phase, patients are candidates for discon-
tinuation of MV if FiO2 is B0.4, PEEP is B5 cmH2O
and no signs of respiratory distress are present. Manual
hyperinﬂation is performed as part of standard airway
care, after disconnection of the ventilator and after
adjustment of MV settings. Recommended tidal volumes
are between 6 and 8 ml/kg PBW. All blood gas results
are shown to the physicians. As part of the team, nurses
can decrease the FiO2 if the PaO2 is higher than 10 kPa
(75 mmHg), but all changes in FiO2 have to be reported
to the physician. Nurses can make ventilator therapy
recommendations, but unit policy mandates that all MV
setting adjustments other than lowering of FiO2 are
ordered by physicians. During the study period no
changes in the MV protocol were made.
Statistical analysis
The statistical analysis was carried out with SPSS 16.01.
An independent samples t-test, one-way ANOVA and the
Kruskal-Wallis test were used as appropriate. Differences
with a p value\0.05 were considered signiﬁcant.
47Results
A total of 148,136 ABG test results were retrieved from
the database, of which 126,778 were obtained during MV.
These ABG tests related to 5,498 mechanically ventilated
patients, of whom 4,880 were ﬁrst admissions. The
demographic data are shown in Table 1. In 44% of the
patients admission was after planned surgery. Trauma
patients represented 4% of the study group. In the neu-
rosurgery group 7% were elective patients and the others
were admitted after urgent surgery for bleeding or trauma.
Of the surgical patients almost 40% were ventilated for
recovery from anaesthesia.
The baseline ventilator settings and adjustments
together with subsequent oxygenation data for all ABG
tests are shown in Table 2. Overall, approximately 40%
of the ABG tests were performed during pressure-con-
trolled MV with a median I:E ratio of 1:2. The mean tidal
volume was 7.5 ± 2.2 ml/kg PBW. In 57% of the ABG
tests the PaO2 was between 8 and 13 kPa (60–98 mmHg),
in more than 40% the PaO2 was [10 kPa (75 mmHg),
and in 22% the PaO2 was [16 kPa (120 mmHg). The
median interval between two successive ABG tests was
166 min (interquartile range 100–258 min). This
decreased signiﬁcantly with a lower PaO2 (P\0.001). The
PEEP and FiO2 were not changed in most patients in any
of the PaO2 groups.
To study the response to hyperoxia, we subcategorized
the highest PaO2 group ([16 kPa,[120 mmHg) based on
the FiO2 (Table 3). In 57% of these ABG tests FiO2 was
exactly 0.4 and 8% had FiO2 \0.4. In only one-quarter
(24.9%) of the ABG tests was the FiO2 decreased. Of the
total group with a PaO2[16 kPa (120 mmHg), at time of
the successive ABG test 11% had FiO2\0.4, with a mean
successive PaO2 of 18 ± 5.9 kPa (135 ± 44 mmHg). At
the time of the successive ABG test 64% had a FiO2 of
exactly 0.4. In the subsequent ABG test 33% had PEEP
above 5 cmH2O. In 78% of cases with PaO2 [16 kPa
(120 mmHg) and FiO2\0.41 neither FiO2 nor PEEP was
adjusted (Table 4). In contrast, in most cases with PaO2
[16 kPa (120 mmHg) and FiO2[0.4, ventilator settings
were adjusted.
Discussion
In this retrospective database study, we found that
hyperoxia (deﬁned as PaO2 [16 kPa, 120 mmHg) was
frequently present in patients but in most cases did not
lead to adjustment of ventilator settings. If the FiO2 was
0.4 or lower the hyperoxia was accepted in the majority of
cases.
Oxygen therapy has been used in the care of critically
ill patients since the early years of the last century.
However, from the beginning of the 1970s increasing
understanding emerged that oxygen therapy can cause
pulmonary toxicity [8]. Baboons were found to have
progressive alveolar septal injury after exposure to 60%
oxygen for 14 days and hyperoxia (FiO2 0.5) exacerbated
lung injury in a large tidal volume model in rabbits [9,
10]. The acute lung injury caused by hyperoxia is char-
acterized by an inﬂux of inﬂammatory cells representing
an alteration in barrier properties of the alveolar capillary
membrane [3]. The systemic effects of hyperoxia are less
clear [11]. Some work has suggested that there is an
important interaction between FiO2 and pulmonary free
radicals potentially leading to an adverse effect on out-
come in ARDS [12]. More recently, Li et al. [13] found in
mice that the combined detrimental effect of oxygen and
repetitive cyclic stretch results in the activation of spe-
ciﬁc independent intracellular signalling pathways,
showing that hyperoxia-induced lung injury is more than
free radical-mediated injury alone. Despite extensive
experimental evidence in animals supporting a direct
injurious effect of high inspired oxygen concentrations,
only few human data exist on this topic. In 1992 a small
study in 12 healthy nonsmoking adults exposed to a
fractional inspired oxygen concentration of 50% (mean
exposure 44 h) showed enhanced oxidative stress and
stimulation of alveolar macrophages in bronchoalveolar
lavage ﬂuid [14]. Little is known about the dose range of
oxygen toxicity. A recent study in Wistar rats found a
dose-dependent hyperoxic lung injury [15]. However, to
our knowledge no studies about the safety of an inspired
oxygen concentration below 40% have been performed.
Moreover, until now no studies concerning oxygen tox-
icity have been conducted in critically ill patients [16].
The fact that neither physicians nor nurses adjusted
ventilator settings in the event of hyperoxia would
be understandable if other clinical signs indicated
Table 1 Patient characteristics of the study population
Characteristic Value
Age (years, mean ± SD) 61 ± 16
Gender M/F (%) 64/36
Height (cm, mean ± SD) 174 ± 9
Actual body weight (kg, mean ± SD) 78 ± 6
Predicted body weight (kg, mean ± SD)
a 67 ± 10












a Men = 50 ? 0.91(height in centimetres - 152.4); women =
45.5 ? 0.91(height in centimetres - 152.4)
48deterioration of pulmonary function. In our study, how-
ever, this is a very unlikely explanation given the fact that
mean PaO2 in the subsequent ABG test was still 18 kPa
(135 mmHg). Another potential but unlikely explanation
would be that physicians and ICU nurses prefer some
level of hyperoxia because monitoring of arterial oxy-
genation is performed relatively infrequently. We found a
median duration between ABG tests of 166 min, which is
equal to almost nine ABG analyses per patient-day.
Signiﬁcantly more ABG samples were taken in the
group with a PaO2 below 8 kPa (60 mmHg). This is more
frequent than described in the past. In 1997, a study found
that after the implementation of a practice guideline for
ABG measurement, the number of tests decreased from
4.9 to 2.4 ABG tests per patient-day [17]. In a Swiss study
the frequency decreased after a guideline from 8.2 to 4.8
tests per patient-day [18]. The high number of ABG tests
in this study may be explained by the fact that blood
glucose was also measured in the blood gas analyser.
Nevertheless, in these cases ABG data were also pre-
sented to the clinician. In addition to frequent ABG
analysis, oxygen saturation is also continuously moni-
tored transcutaneously in all our patients. Rice et al. [19]
demonstrated in a medical patient population that pulse
oximetric saturation/FiO2 correlates with PaO2/FiO2
ratios, and thus may serve as a surrogate for the follow-up
of mechanically ventilated critically ill patients. Thus,
unnoticed hypoxaemia is unlikely to occur and there
seems to be no reason for preferring some level of
hyperoxia.




























\8 4,544 (3.6) 7.3 ± 0.7 0.5 (0.4–0.61) 10 (7–12) 95 (56–159) 0 (0–0.1) 0 (0–2) 2.8 ± 4.6 3,749 (83)
8.01–10 21,335 (16.8) 9.2 ± 0.6 0.45 (0.4–0.51) 9 (5–12) 143 (87–228) 0 (0–0) 0 (0–0) 1.5 ± 3.2 17,071 (80)
10.01–13 45,545 (35.9) 11.5 ± 0.8 0.4 (0.4– 0.5) 8 (5–10) 174 (108–264) 0 (0–0) 0 (0–0) 0.6 ± 3.1 32,973 (72)
13.01–16 27,132 (21.4) 14.4 ± 0.9 0.4 (0.4–0.42) 5 (5–10) 181 (111–276) 0 (0–0) 0 (0–0) -0.4 ± 3.4 18,297 (67)
[16.01 28,222 (22.3) 20.7 ± 6.0 0.4 (0.4–0.45) 5 (5–10) 166 (99–261) 0 (0–0) 0 (0–0) -2.6 ± 6.4 17,527 (62)
Data are presented as medians (interquartile range) unless otherwise stated
a Delta difference between successive ABG tests
Table 3 Oxygenation data, ventilator settings and adjustments in subcategory with PaO2[16 kPa
FiO2 n (%) PaO2







(kPa, mean ± SD)
b
0.21–0.4
a 18,287 (65) 19.8 ± 3.6 5 (5–6) 0 (0–0) 0 (0–0) -1.5 ± 4.5
0.41–0.6 8,451 (30) 21.1 ± 5.7 8 (5–10) -0.05 (-0.1 to 0) 0 (0–0) -3.8 ± 6.4
0.61–0.8 866 (3) 23.8 ± 8.2 12 (10–15) -0.15 (-0.2 to 0.1) 0 (0–0) -7.3 ± 8.6
0.81–1.0 618 (2) 38.9 ± 18.9 10 (5–15) -0.3 (-0.5 to -0.15) 0 (0–0) -17.4 ± 18
Data are presented as medians (interquartile range) unless otherwise stated
a In 88% of this group FiO2 = 0.4
b Delta difference between successive ABG tests





No decrease in FiO2
or PEEP, n (%)
0.21–0.4
a 998 (6) 3,090 (17) 14,289 (78)
0.41–0.6 4,810 (57) 1,798 (21) 2,994 (35)
0.61–0.8 715 (83) 174 (20) 130 (15)
0.81–1.0 496 (81) 105 (17) 114 (18)
a In 88% of this group FiO2 = 0.4
49In our study, many patients were admitted after elec-
tive surgery, recovering from anaesthesia. These patients
may have been disconnected from the ventilator when
PaO2 was high and FiO2 was 0.4. However, as only ABG
tests were included when patients were on mechanical
ventilation, this is no explanation for our ﬁndings. Fur-
thermore, some patients had a very high FiO2 (0.81–1.0)
as well as a high mean PaO2 of 39 kPa (Table 3). This
group only represents 0.5% of the total group of ABG
tests. Explanations for unusually high PaO2 values may
include dysfunctioning pulse oximetric saturation mea-
surements leading to high FiO2, treatment for CO
intoxication or hyperoxygenation during or after tracheal
suction.
High PaO2 values only led to adjustment of inspired
oxygen concentration if FiO2 was higher than 0.4. Our
protocol mandates a target PaO2 above 10 kPa
(75 mmHg) and suggests decreasing the FiO2 to 0.21 if
the PaO2 is above 10 kPa (75 mmHg). Furthermore, 33%
of the group with PaO2 [16 kPa (120 mmHg) still had
PEEP above 5 cmH2O in the subsequent ABG test. Pre-
vious reports from our institution show that feedback and
education improve physician compliance in the use of
lung-protective MV [20]. It seems very likely that feed-
back, education and adjusted protocols concerning
oxygenation will improve the weaning to a minimal FiO2
of 0.21 and minimal PEEP level. Apparently, physicians
and nurses do not consider hyperoxia as potentially haz-
ardous if FiO2 is lower than 0.41 and do not adjust
ventilator settings in these circumstances. Interestingly, in
a questionnaire study from 1999, similar attitudes were
reported among Canadian intensivists. Whereas high
oxygen saturation measurements would urge intensivists
to lower FiO2 in almost all cases when FiO2 was higher
than 0.4, only 54% of respondents would alter oxygen
administration if FiO2 was lower than 0.4 [6].
Our study is the ﬁrst to reveal adjustments of venti-
lator settings by intensivists and ICU nurses in the event
of hyperoxia in intensive care patients. The main limita-
tion of this study was the fact that it was a single-centre
study. We do not know whether responses to hyperoxia
are the same in other ICUs in the Netherlands or other
countries. Another limitation of this study is that the
clinical condition of the patient may inﬂuence decisions
to change ventilator settings and that no information on
the condition of the patients was available for this anal-
ysis. Also, we do not know whether hyperoxia is
detrimental in critically ill patients, e.g. by increasing the
severity of lung injury.
Conclusion
Hyperoxia was frequently present in ICU patients but in
most cases did not lead to adjustment of ventilator set-
tings. If FiO2 was 0.4 or lower the hyperoxia was
accepted in the majority of cases. Further research is
needed concerning the effects of frequently encountered
hyperoxia in ICU patients. For now and given the
experimental evidence of hyperoxia-induced damage, it
seems wise to emphasize in guidelines that hyperoxia
should be limited to what is needed to ensure adequate
tissue oxygenation.
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